Balaji Healthline

Famotidine Tablets 20 mg Sustained Release is a combination formulation designed to provide prolonged acid suppression in conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Famotidine, a potent H2-receptor antagonist, works by reducing the production of stomach acid, thereby alleviating symptoms like heartburn, acid reflux, and indigestion. The sustained release (SR) mechanism ensures a gradual and extended release of the active ingredient, maintaining therapeutic levels in the bloodstream over a longer period, typically allowing for once-daily dosing. This formulation is particularly beneficial for patients requiring consistent acid control and improved compliance through reduced dosing frequency.

Famotidine Tablets 40 mg Sustained Release is a combination medication designed to provide prolonged relief from gastric acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Famotidine is a potent H2-receptor antagonist that works by inhibiting histamine-induced acid secretion in the stomach, thereby reducing acidity and promoting healing of the gastric and duodenal lining. The sustained-release formulation ensures a gradual and consistent release of the active ingredient over an extended period, allowing for prolonged therapeutic effects and improved patient compliance with once-daily dosing. This formulation is particularly beneficial for individuals requiring continuous acid suppression and is usually administered under medical supervision to manage and prevent recurrence of acid-related conditions.